Iguratimod

Iguratimod
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Overview of the drug Iguratimod

Iguratimod is a disease-modifying antirheumatic drug (DMARD) used primarily in the treatment of rheumatoid arthritis. It is known for its anti-inflammatory and immunomodulatory effects. Iguratimod is particularly noted for its ability to inhibit the production of inflammatory cytokines and the activation of NF-_B.

Mechanism of Action[edit | edit source]

Iguratimod works by modulating the immune response. It inhibits the production of pro-inflammatory cytokines such as TNF-_, IL-1, and IL-6. Additionally, it suppresses the activation of NF-_B, a transcription factor that plays a key role in the inflammatory response. This dual action helps reduce inflammation and slow the progression of joint damage in rheumatoid arthritis.

Pharmacokinetics[edit | edit source]

Iguratimod is administered orally and is absorbed through the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the urine. The drug has a half-life that allows for once-daily dosing, which can improve patient compliance.

Clinical Use[edit | edit source]

Iguratimod is used in the management of rheumatoid arthritis, particularly in patients who have not responded adequately to other DMARDs. It can be used as monotherapy or in combination with other antirheumatic drugs such as methotrexate.

Side Effects[edit | edit source]

Common side effects of iguratimod include gastrointestinal disturbances, such as nausea and diarrhea, as well as liver enzyme elevations. Patients on iguratimod require regular monitoring of liver function tests. Less commonly, it may cause leukopenia or thrombocytopenia.

Contraindications[edit | edit source]

Iguratimod is contraindicated in patients with known hypersensitivity to the drug. It should be used with caution in patients with liver impairment or a history of liver disease.

Related Pages[edit | edit source]

Iguratimod

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.